News
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
19 Apr 24
Biotech, Government, News, Health Care, Top Stories, Markets, General
Once Valued At Billions, 23andMe's CEO Considers Privatization To Secure Company's Future
18 Apr 24
Biotech, M&A, News, Health Care, Top Stories, Movers, Trading Ideas, General
GSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Years
17 Apr 24
Biotech, Large Cap, News, Health Care, Top Stories, General
GSK's EAGLE-1 Phase 3 Data Show Potential For Gepotidacin As A New Oral Treatment Option For Uncomplicated Urogenital Gonorrhea
17 Apr 24
Biotech, Large Cap, News, Health Care, General
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
11 Apr 24
News, Dividends, Health Care, Price Target, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General
CureVac, GSK Partner Release Data On Influenza Vaccine Study
4 Apr 24
Biotech, Large Cap, News, Health Care, General
In Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster
4 Apr 24
Biotech, Large Cap, News, Health Care, Legal, General
CureVac Announces Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
4 Apr 24
News
Peering Into GSK's Recent Short Interest
26 Mar 24
Short Sellers, Short Ideas, Trading Ideas
Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month
21 Mar 24
Biotech, Large Cap, News, Health Care, General
GSK Reveals New Phase 3 Data For Jemperli Combo Therapy To Support Expanded Use Approval For Wider Endometrial Cancer
18 Mar 24
Biotech, Equities, Large Cap, News, Health Care, General
Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B
18 Mar 24
Large Cap, M&A, News, Health Care, General
Reported Saturday, GSK Announced RUBY Phase III Data Show Potential For Jemperli (Dostarlimab-Gxly) Combinations In More Patients With Primary Advanced Or Recurrent Endometrial Cancer
18 Mar 24
News
Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
11 Mar 24
Analyst Color, Asia, Biotech, Equities, Large Cap, Macro Economic Events, Mid Cap, Broad U.S. Equity ETFs, Emerging Markets, Eurozone, Top Stories, Economics, Analyst Ratings, Tech, ETFs, General
GSK's Withdrawn Multiple Myeloma Drug Shows Encouraging Combination Therapy Data In Second Late-Stage Study
7 Mar 24
Biotech, Large Cap, News, Health Care, Movers, Trading Ideas, General
GSK's Headline Results From Interim Analysis Of DREAMM-8 Phase 3 Head-To-Head Trial Of Blenrep Plus Pomalidomide Plus Dexamethasone, Versus Standard Of Care As Second Line Treatment For Relapsed/Refractory Multiple Myeloma Show Trial Met Primary Endpoint
7 Mar 24
Biotech, Large Cap, News, Health Care, General
Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows
6 Mar 24
Biotech, Large Cap, News, Health Care, Movers, General
10 Health Care Stocks Whale Activity In Today's Session
6 Mar 24
Options
Pfizer/GSK-Backed ViiV Healthcare's HIV Drug Associated With Increased Resistance, WHO Report Says
5 Mar 24
Biotech, Large Cap, News, Health Care, Global, General
ViiV Healthcare Presents Phase I Clinical Trial Findings Of A Cabotegravir Long-Acting Injectable Investigational Formulation Allowing At Least 4-Months Between Doses
4 Mar 24
Biotech, News, General
Press releases
WuXi Biologics Reports Solid 2023 Annual Results
26 Mar 24
Earnings, Press Releases
Thinking about trading options or stock in Advanced Micro Devices, Amazon.com, Intel, GSK, or Viking Therapeutics?
21 Mar 24
Opinion, Press Releases
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer
16 Mar 24
Press Releases
Global Contraceptive Drugs Market Size is Projected to Reach USD 28.96 billion by 2030, Growing at a CAGR of 7.3%: Straits Research
12 Mar 24
News, Health Care, Analyst Ratings, Press Releases
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
7 Mar 24
Press Releases
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer's Disease
8 Feb 24
Press Releases
23andMe Reports Third Quarter Fiscal 2024 Financial Results
7 Feb 24
Earnings, Press Releases
FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
7 Feb 24
Health Care, Press Releases
Respiratory Syncytial Virus (RSV) Market is Set to Grow at a Remarkable Growth During by 2032 | Shionogi, Curevac, Reviral, Pfizer, Sanofi, Biocomo, Virometix
6 Feb 24
News, Press Releases
GSK's RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased Risk
6 Feb 24
Press Releases
Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen's Cell-Free DNA Production Technology
24 Jan 24
Press Releases